259 related articles for article (PubMed ID: 23676544)
1. Basaloid carcinoma of the prostate: an extremely rare tumor.
Rodriguez-Carlin A; Arellano L; López-Fontana G; Bolufer E; Castillo OA
Arch Esp Urol; 2013 May; 66(4):380-4. PubMed ID: 23676544
[TBL] [Abstract][Full Text] [Related]
2. Basal cell carcinoma of the prostate: a clinicopathologic study of 29 cases.
Ali TZ; Epstein JI
Am J Surg Pathol; 2007 May; 31(5):697-705. PubMed ID: 17460452
[TBL] [Abstract][Full Text] [Related]
3. Basal cell proliferations of the prostate other than usual basal cell hyperplasia: a clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification.
McKenney JK; Amin MB; Srigley JR; Jimenez RE; Ro JY; Grignon DJ; Young RH
Am J Surg Pathol; 2004 Oct; 28(10):1289-98. PubMed ID: 15371944
[TBL] [Abstract][Full Text] [Related]
4. Cylindroma of the prostate.
Bauer R
Am J Surg Pathol; 2007 Aug; 31(8):1288-91. PubMed ID: 17667556
[TBL] [Abstract][Full Text] [Related]
5. Basal cell carcinoma of the prostate: current concepts.
Ayyathurai R; Civantos F; Soloway MS; Manoharan M
BJU Int; 2007 Jun; 99(6):1345-9. PubMed ID: 17419700
[No Abstract] [Full Text] [Related]
6. Basal cell carcinoma of the prostate: a case report.
Stearns G; Cheng JS; Shapiro O; Nsouli I
Urology; 2012 Jun; 79(6):e79-80. PubMed ID: 22656427
[TBL] [Abstract][Full Text] [Related]
7. [A case of ductal carcinoma of the prostate after transurethral resection of prostate].
Izumi K; Kanno H; Umemoto S; Hasumi H; Osada Y; Ota J; Tsuchiya F; Ogino I; Harada M
Hinyokika Kiyo; 2007 May; 53(5):315-8. PubMed ID: 17561717
[TBL] [Abstract][Full Text] [Related]
8. Basaloid carcinoma of the prostate gland. An unusual finding.
Parada DD; López CA; Moreira O
Arch Esp Urol; 2004 Jun; 57(5):573-8. PubMed ID: 15382579
[TBL] [Abstract][Full Text] [Related]
9. Adenoid cystic carcinoma of the prostate: case report on a rare entity and review of the literature.
Ahuja A; Das P; Kumar N; Saini AK; Seth A; Ray R
Pathol Res Pract; 2011 Jun; 207(6):391-4. PubMed ID: 21440997
[TBL] [Abstract][Full Text] [Related]
10. Adenoid cystic/basal cell carcinoma of the prostate: review and update.
Begnami MD; Quezado M; Pinto P; Linehan WM; Merino M
Arch Pathol Lab Med; 2007 Apr; 131(4):637-40. PubMed ID: 17425398
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic radical prostatectomy in a cadaveric renal transplant patient: first case in Thailand and the authors first experience--a case report.
Saema A; Patcharatrakul S; Kongchareonsombat W
J Med Assoc Thai; 2013 May; 96(5):633-6. PubMed ID: 23745320
[TBL] [Abstract][Full Text] [Related]
12. Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma.
Boran C; Kandirali E; Yilmaz F; Serin E; Akyol M
Urol Oncol; 2011; 29(6):614-23. PubMed ID: 20189848
[TBL] [Abstract][Full Text] [Related]
13. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD
Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714
[TBL] [Abstract][Full Text] [Related]
15. Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?
de la Taille A; Rubin MA; Bagiella E; Olsson CA; Buttyan R; Burchardt T; Knight C; O'Toole KM; Katz AE
J Urol; 1999 Jul; 162(1):103-6. PubMed ID: 10379750
[TBL] [Abstract][Full Text] [Related]
16. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
[TBL] [Abstract][Full Text] [Related]
17. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
[TBL] [Abstract][Full Text] [Related]
18. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
Stock RG; Stone NN; Ianuzzi C; Unger P
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
[TBL] [Abstract][Full Text] [Related]
19. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
20. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
